SecBot SecBot
DEFA14A ·Filed Apr 22, 2026

CERS

CERUS CORP
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001020214-26-000012
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the shareholder vote results for the equity incentive plan amendment, as the 10 million new shares represent significant potential dilution. The recent severance plan adoption suggests internal changes, but the proxy itself is routine.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
CERS ▲ +61.34% at T+60d
NEUTRAL call +61.34% · α vs SPY +56.56% · entry $1.94 → $3.13
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
-2.06%
call -2.06% · α -1.67%
$1.90
settled 6mo ago
T+5d
-0.52%
call -0.52% · α -0.57%
$1.93
settled 6mo ago
T+20d
+39.18%
call +39.18% · α +36.01%
$2.70
settled 5mo ago
T+60d
+61.34%
call +61.34% · α +56.56%
$3.13
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Cerus Corporation filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, proposing the election of two directors, an increase in shares for its equity incentive plan, advisory approval of executive compensation, and ratification of its auditor. This filing follows a recent 8-K filing announcing a new severance plan for executives, suggesting board-level changes are materializing.

Key Financial Metrics

Vote
director election
Meeting
2026-06-02
Seats Contested
2

Key Facts

  • Proposes election of two nominees for director: William M. Greenman and Ann Lucena.
  • Seeks approval to increase shares in the 2024 Equity Incentive Plan by 10 million.
  • Requests advisory approval of named executive officer compensation.
  • Seeks ratification of Ernst & Young LLP as the independent auditor.
  • Follows a recent 8-K filing (Items: 5.02) that established a new severance plan for certain executive officers.

Financial Impact

The plan amendment would authorize 10 million additional shares for issuance.

dilution

Risk Factors

  • Potential shareholder opposition to the significant increase in shares for the equity incentive plan.
  • The new severance plan could signal executive turnover or strategic shifts.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001020214-26-000012
Document: 0001020214-26-000012-index-headers.html0001020214-26-000012
Document: 0001020214-26-000012-index.html0001020214-26-000012
Document: 0001020214-26-000012.txt0001020214-26-000012
9 reports for CERS
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+5▲ +12.44%Mar 6, 2026
Filters
Rows
Reports for CERS — sortable, filterable
TypeNow
Jul 21, 2026
13w ago
GOVT-CONTRACT
BULLISH ★ 7/10
$3.02 $2.85▼ −5.63%▼ −8.53%$2.37 (−21.52%)
Jul 2, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.16 $2.89▼ −8.54%▼ −8.13%$2.37 (−25.00%)
Jul 2, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.16 $2.89▼ −8.54%▼ −8.13%$2.37 (−25.00%)
Apr 30, 2026
25w ago
8-K
BULLISH ★ 7/10
$2.72 $2.84▲ +4.41%▼ −0.87%$2.37 (−12.87%)
Apr 22, 2026
26w ago
DEFA14A
NEUTRAL ★ 3/10
$1.94 $2.70▲ +39.18%▲ +36.01%$2.37 (+22.16%)
Apr 21, 2026
26w ago
8-K
NEUTRAL ★ 3/10
$1.94 $2.70▲ +39.18%▲ +36.01%$2.37 (+22.16%)
Mar 6, 2026
33w ago
Insider Cluster
BEARISH ★ 6/10
$1.93 $1.85▲ +4.15%▲ +2.10%$2.37 (−22.80%)
Mar 6, 2026
33w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.93 $1.85▼ −4.15%▼ −2.10%$2.37 (+22.80%)
Mar 5, 2026
33w ago
Insider Cluster
NEUTRAL ★ 4/10
$2.04 $1.86▼ −8.82%▼ −5.03%$2.37 (+16.18%)
Showing 9 of 9

US Market Status

Market Closed — Opens Tue (16h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026